Related Experiment Video
Updated: Jul 14, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution
Ioannis Moyssakis1, Maria G Tektonidou, Vassilios A Vasilliou
1Department of Cardiology, Laiko General Hospital, Athens, Greece.
Libman-Sacks endocarditis affects about 11% of systemic lupus erythematosus patients, linked to disease activity and antiphospholipid syndrome. Valve lesions can worsen over time.
Area of Science:
- Cardiology
- Rheumatology
- Internal Medicine
Background:
- Libman-Sacks endocarditis is a rare valvular heart disease.
- Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect multiple organs, including the heart.
Purpose of the Study:
- To determine the prevalence and progression of Libman-Sacks endocarditis in SLE patients.
- To investigate associations between valvulopathy and clinical/laboratory characteristics in SLE.
Main Methods:
- Doppler echocardiography in 342 SLE patients.
- Clinical and laboratory data collection.
- 4-year follow-up with repeat echocardiography.
Main Results:
- Libman-Sacks endocarditis found in 11% of patients, primarily affecting mitral and aortic valves.
- Associations noted with disease duration, activity, thromboses, stroke, thrombocytopenia, anticardiolipin antibodies, and antiphospholipid syndrome.
- Progression of valve lesions observed during follow-up, with some patients developing severe regurgitation or stenosis.
Conclusions:
- Libman-Sacks vegetations are present in approximately 1 in 10 SLE patients.
- Valvulopathy is associated with disease duration, activity, anticardiolipin antibodies, and antiphospholipid syndrome.
- Progression of valve lesions is possible over long-term follow-up.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Rheumatic Heart Disease I: Introduction
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
